摘要:
The invention relates to iron(III) complexes and pharmaceutical compositions in which they are present for use as medicaments, in particular for the treatment and/or prophylaxis of iron deficiency symptoms and iron deficiency anaemias.
摘要:
A new method for the synthesis of L-Glutamyl-γ-D-Glutamic acid and its use in the synthesis of (2R)-((4S)-carboxy-4-(4, N -(((6S)-2-(hydroxymethyl)-4-oxo-3,4,7,8- tetrahydro-3 H -cyclopenta[g]quinazolin-6-yl)- N -(prop-2-ynyl)amino)benzamido) butanamido)pentanedioic acid, 1 are provided. Also provided is an efficient method for the isolation and purification of the trisodium salt of the abovementioned acid, 2 , in a form suitable for long term storage and use in a parenteral dosing form.
摘要:
The invention relates to tetrahydronaphthalene derivatives of general formula (I), to a method for their production and to their use as anti-inflammatory agents.
摘要:
The present invention relates to compounds of Formula (I), wherein R2, R3, R4, R9, Ar, UC, X, Y, Q, n and p are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases.
摘要:
The following phenylalanine derivative having an α4 integrin inhibitory effect, its analogs and remedies for various diseases in which α4 integrin participates.
摘要:
The invention disclosed a new process of asymmetric alkynylation of ketone or ketimine, involving the chiral ligand-mediated asymmetric addition of zinc or copper acetylide to a trifluoromethyl ketone or ketimine intermediate to give a chiral tertiary proparglic alcohols or amines. The adduct compounds include the key precursors to the potent HIV reverse transcriptase inhibitor Efavirenz (DMP 266), DPC 961 and DPC 083 .The invention also disclosed a novel chiral amino alcohol ligand.